Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-VEGFR3/FLT4 Antibody (7C228)

😃Good
Catalog No. TMAY-03365
Alias VEGFR-3, VEGFR3, VEGF Receptor 3, PCL, LMPH1A, fms related tyrosine kinase 4, FLT-41, FLT41, FLT-4

Anti-VEGFR3/FLT4 Antibody (7C228) is a Rabbit antibody targeting VEGFR3/FLT4. Anti-VEGFR3/FLT4 Antibody (7C228) can be used in ELISA.

Anti-VEGFR3/FLT4 Antibody (7C228)

Anti-VEGFR3/FLT4 Antibody (7C228)

😃Good
Catalog No. TMAY-03365Alias VEGFR-3, VEGFR3, VEGF Receptor 3, PCL, LMPH1A, fms related tyrosine kinase 4, FLT-41, FLT41, FLT-4
Anti-VEGFR3/FLT4 Antibody (7C228) is a Rabbit antibody targeting VEGFR3/FLT4. Anti-VEGFR3/FLT4 Antibody (7C228) can be used in ELISA.
Pack SizePriceAvailabilityQuantity
100 μL$269 7-10 days
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Anti-VEGFR3/FLT4 Antibody (7C228) is a Rabbit antibody targeting VEGFR3/FLT4. Anti-VEGFR3/FLT4 Antibody (7C228) can be used in ELISA.
AliasVEGFR-3, VEGFR3, VEGF Receptor 3, PCL, LMPH1A, fms related tyrosine kinase 4, FLT-41, FLT41, FLT-4
Ig Type
Monoclonal Rabbit IgG
Clone
7C228
Reactivity
Mouse
Application
ELISA
Recommended Dose
ELISA: 1:5000-1:10000
Antibody Type
Monoclonal
Host SpeciesRabbit
ConstructionThis antibody was obtained from a rabbit immunized with purified, recombinant Mouse VEGFR3 / FLT-4 (rM VEGFR3 / FLT-4; TMPY-01936; P35917-1; Met1-Glu775).
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundVascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT-4, together with the other two members VEGFR1 (FLT-1) and VEGFR2 (KDR/Flk-1) are receptors for vascular endothelial growth factors (VEGF) and belong to the class III subfamily of receptor tyrosine kinases (RTKs). The VEGFR3 protein is expressed mainly on lymphatic vessels but it is also up-regulated in tumor angiogenesis. Mutations in VEGFR3 have been identified in patients with primary lymphoedema. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer (NSCLC), and so on.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Mouse VEGFR3 / FLT-4 protein (TMPY-01936)
Antigen Species
Mouse
Biology Area
Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs)
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Anti-VEGFR3/FLT4 Antibody (7C228) | purchase Anti-VEGFR3/FLT4 Antibody (7C228) | Anti-VEGFR3/FLT4 Antibody (7C228) cost | order Anti-VEGFR3/FLT4 Antibody (7C228)